This week, researchers, entrepreneurs and investors have joined together for the annual flagship event, MedTech World, this year held in Malta.
Malta is a hub for tech and innovation – making it the perfect location to host 2024’s MedTech World conference showcasing the boldest innovators and brightest minds in medtech.
Featuring the very latest advancements in the world of healthcare and health technology, MedTech World Malta features panels, presentations, pitches, investor and CEO forums, and networking opportunities, along with the chance for attendees to spark new ideas and partnerships.
Organised by Co-Chairs Dr. Dylan Attard, Med Tech World CEO and Founder, and Giovanni Lauricella, CEO of Lifeblood, this year’s conference featured an investor forum, keynote speeches, live technology demos, and themes explored artificial intelligence, startups and entrepreneurship, medical devices, digital innovation and much more.
From tackling health misinformation to using AI to detect cancer, liquid biopsies, patients owning their own data and engineers showcasing their medical device inventions – the conference explored the depths of how technology is changing the future of healthcare and how stakeholder and healthcare professionals can navigate this new landscape.
“Our annual flagship event is a unique opportunity to bring together pioneers who are not only transforming healthcare but reshaping how we think about medical technology’s potential,” said Dr. Attard.
“Each year, we carefully tailor this experience to reflect the evolving needs of our community, ensuring that every attendee—from CEOs to investors and researchers—finds value in every moment.”
FINN Partners Julie Adrian, Managing Partner and UK Health Group Lead, moderated a discussion around ensuring inclusivity when implementing Artificial Intelligence (AI) for health technology solutions.
Professor Georgi Chaltikyan, MD, PhD, panel participant, commented: “We have just recently seen the emergence of large, sophisticated data models that enable the creation of highly customised, tailored applications.
“These now need to be fine-tuned for specific local contexts, catering to diverse, unique needs and socio-economic backgrounds. A network of centres are now needed that are solely concerned with inclusive AI models, and one which is monitored.”
Philippe Gerwill of AI 2030 added: “We need new skills in the regulatory environment, it’s a huge challenge and a new world. We can’t act with fear.”
Stay tuned for more coverage from MedTech World Malta.
